Great Point Partners LLC Point Biopharma Global Inc. Transaction History

Great Point Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.67 - $9.71 $600,566 - $874,288	-90,040 Reduced 3.0%	2,909,960 $19.4 Million
Q2 2023 Aug 14, 2023	SELL	$6.86 - $10.86 $2.63 Million - $4.16 Million	-383,029 Reduced 11.32%	3,000,000 $27.2 Million
Q1 2023 May 15, 2023	BUY	$6.78 - $8.1 $5.7 Million - $6.81 Million	841,250 Added 33.1%	3,383,029 $24.6 Million
Q4 2022 Feb 14, 2023	SELL	$5.72 - $9.78 $5.83 Million - $9.97 Million	-1,019,205 Reduced 28.62%	2,541,779 $18.5 Million
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $8.26 Million - $11.8 Million	1,140,483 Added 47.12%	3,560,984 $27.5 Million
Q2 2022 Aug 15, 2022	BUY	$5.6 - $9.5 $2.02 Million - $3.42 Million	360,501 Added 17.5%	2,420,501 $16.5 Million
Q1 2022 May 16, 2022	BUY	$5.46 - $8.13 $10.2 Million - $15.2 Million	1,869,480 Added 981.25%	2,060,000 $16.4 Million
Q4 2021 Feb 14, 2022	BUY	$4.83 - $9.75 $920,211 - $1.86 Million	190,520 New	190,520 $1.07 Million

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.